World Interventional Cardiology & Peripheral Vascular Devices Market - Opportunities and Forecasts, 2014 - 2020

World Interventional Cardiology & Peripheral Vascular Devices Market - Opportunities and Forecasts, 2014 - 2020

Category : Medical Devices

------------ Or -------------

Interventional cardiology & peripheral vascular devices market is driven by increasing count of aging population and rising demand for angioplasty procedures which are minimally invasive. Furthermore, technological enhancements in interventional cardiology & peripheral vascular devices is expected to boost the market growth. The application of preliminary conventional first-level medication and rising cases of product recall is expected to hinder the market growth. Demand of stents having bioabsorbable properties across emerging markets is anticipated to offer abundant growth opportunities. Irregularity in reimbursements along with entry barriers for new players are the key market challenges.

The market is segmented on the basis of types of devices, procedure and geography. On the basis of types, the market is segmented into angioplasty stents market and catheters market. On the basis of procedure, the market is segmented into endovascular aneurysm repair (EVAR), stent grafts market, inferior vena cava (IVC) filters market, plaque modification devices market, hemodynamic flow alteration devices market and accessories market. On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).

Key market players profiled in this report are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Cordis Corporation (A Subsidiary of Johnson & Johnson Co.), Medtronic, Inc., Spectranetics International BV, St. Jude Medical, Inc. and Terumo Corporation.


  • The report provides a comprehensive analysis of current & future market trends, key market challenges and emerging avenues for the growth of this market globally.
  • The report offers latest technological innovations and the recent R&D developments.
  • The report offers an insight into competitive landscape in terms of new technological developments, untapped segments, and value chain analysis.
  • This report entails the detailed quantitative analysis of the current market and estimations through 2014 and 2020, which assists in identifying the prevailing opportunities.
  • The report offers detailed segmentation and analyzes the key segments in terms of market size by value and volume and country-level analysis to provide an in-depth understanding.
  • Porters Five Forces analysis is offered in the report along with highlighting bargaining power of buyers and suppliers.
  • The report offers strategic analysis of financial status of key players, and highlights market share of main vendors.
  • The report offers information on the status of new projects along with offering investment feasibility analysis of the same.


  • By Type
    • Angioplasty Stents Market
    • Catheters Market
  • By Device
    • Endovascular Aneurysm Repair (EVAR)
    • Stent Grafts Market
    • inferior vena cava (IVC) Filters Market
    • Plaque Modification Devices Market
    • Hemodynamic Flow Alteration Devices Market
    • Accessories Market
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • LAMEA

Key Company Profile

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • C.R. Bard
  • Cordis Corporation (A Subsidiary of Johnson & Johnson Co.)
  • Medtronic, Inc.
  • Spectranetics International BV
  • St. Jude Medical, Inc.
  • Terumo Corporation.
The Report is under production. Please fill in the form below to request for a TOC

Enquiry Before Buy